SLC25A1 Drives Cisplatin Resistance in HNSCC via Senescence
2026-05-04
Li et al. demonstrate that upregulation of SLC25A1 in head and neck squamous cell carcinoma (HNSCC) induces chemoresistance to cisplatin by promoting cellular senescence through H3K27 acetylation–mediated gene activation. These insights identify SLC25A1 as both a predictive biomarker and a candidate therapeutic target for overcoming cisplatin resistance in HNSCC.
BicD and MAP7 Synergize to Activate Drosophila Kinesin-1
2026-05-03
This study uncovers how the adaptor protein BicD and the microtubule-associated protein MAP7 jointly activate homodimeric Drosophila kinesin-1 through distinct but complementary mechanisms. The findings clarify adaptor-mediated relief of kinesin auto-inhibition and highlight the interplay between cargo adaptors and microtubule-binding proteins in intracellular transport regulation.
PP2A-Regulated Autophagy Drives Drug Resistance in C. albica
2026-05-02
This study identifies protein phosphatase 2A (PP2A) as a key regulator of autophagy-mediated drug resistance in Candida albicans biofilms. By dissecting the molecular mechanism involving ATG protein phosphorylation, the research reveals new therapeutic entry points for managing biofilm-associated antifungal resistance.
Demethyleneberberine Inhibits NF-κB/MAPK to Attenuate Hepati
2026-05-02
This study demonstrates that Demethyleneberberine (DMB), a natural isoquinoline alkaloid, attenuates concanavalin A-induced autoimmune hepatitis in mice by inhibiting NF-κB and MAPK signaling. The findings highlight DMB’s mechanistic action on inflammatory pathways, positioning it as a promising tool for autoimmune hepatitis research and pathway-targeted disease modeling.
Tofacitinib Citrate in Immune Modulation: Mechanisms and Str
2026-05-01
This thought-leadership article explores the mechanistic and strategic landscape of tofacitinib citrate (CP-690550 citrate) in immune regulation and inflammatory disorder research. Integrating recent findings on cardiovascular safety and endothelial cell function, it provides translational researchers with actionable guidance for dissecting JAK-STAT signaling, optimizing experimental design, and responsibly modeling disease with APExBIO’s trusted reagent.
Disrupting Tumor pH Homeostasis with Biomimetic Microparticl
2026-04-30
This study introduces a biomimetic microparticle system that disrupts both intracellular and extracellular pH balance in tumor cells. By targeting lactate export and activating immunogenic cell death, the approach synergizes chemotherapy and immunotherapy for enhanced tumor suppression.
DAPT (GSI-IX): Applied Protocols in Notch and APP Research
2026-04-30
DAPT (GSI-IX) stands out as a selective γ-secretase inhibitor, empowering researchers to dissect Notch signaling and amyloid precursor protein processing across neurodegeneration, oncology, and regenerative science. This guide translates recent cell culture breakthroughs and disease model strategies into actionable protocols, troubleshooting advice, and advanced workflow integrations.
Spleen-Targeted Neoantigen mRNA Vaccine Drives TLS in HCC
2026-04-29
This study demonstrates that a spleen-targeted neoantigen mRNA vaccine (STNvac) elicits potent antitumor immunity in hepatocellular carcinoma (HCC) by activating ISG15+ CD8+ T cells and promoting tertiary lymphoid structure (TLS) formation. The results highlight the mechanistic importance of GZMA-F2R signaling in this process and suggest new avenues for mRNA vaccine optimization in immunologically cold tumors.
GLP-1 (9-36) Amide: Precision Antagonism for Translational I
2026-04-29
This article examines the mechanistic and translational power of GLP-1 (9-36) amide as a benchmark tool for dissecting GLP-1 receptor signaling, with an emphasis on recent evidence exposing receptor cross-reactivity and the strategic implications for metabolic disease research. It delivers actionable guidance for researchers aiming to optimize their experimental design and interpret complex GPCR interplay, while differentiating the discussion from standard product pages by integrating cross-study insights and forward-looking perspectives.
Actinomycin D: Mechanisms, Evidence, and Research Workflows
2026-04-28
Actinomycin D (ActD) is a potent transcriptional inhibitor widely used in cancer research for dissecting RNA synthesis, apoptosis induction, and cellular responses to DNA damage. Its primary action is DNA intercalation, resulting in transcriptional stress and apoptosis in dividing cells. This article presents atomic, referenced facts regarding its mechanism, benchmarks, and protocol parameters.
Structural Basis for MK 0893 Allosteric Inhibition of GCGR
2026-04-28
The reference paper reveals the high-resolution structure of human glucagon receptor (GCGR) bound to the antagonist MK 0893, uncovering an unexpected extra-helical allosteric binding site. These findings clarify the molecular mechanism of small-molecule GCGR inhibition and offer new avenues for rational design of type 2 diabetes therapeutics.
O-GlcNAcylation Rewires Glycolysis for Wnt-Driven Bone Forma
2026-04-27
This study reveals that O-GlcNAcylation is essential for Wnt-stimulated bone formation by modulating aerobic glycolysis in osteoblasts. By dissecting the Ca2+-PKA-GFAT1 axis and the role of PDK1 stabilization, the authors clarify how post-translational modification controls glucose metabolism and osteogenesis, with implications for osteoporosis therapy.
BET Inhibition in HPV-16 HNSCC: Transcriptional Heterogeneit
2026-04-27
This study investigates how BET protein inhibition affects viral and cellular gene expression in HPV-16 associated head and neck squamous cell carcinoma (HNSCC). By revealing heterogeneous responses among HPV+ cell lines and clarifying the mechanistic link between BRD4 activity and viral oncogene regulation, the research advances understanding of targeted epigenetic therapies in virally driven cancers.
Triiodothyronine (T3) for Advanced Metabolic Regulation Rese
2026-04-26
Unlock the full potential of Triiodothyronine (T3) in metabolic research with refined workflows, troubleshooting strategies, and evidence-based protocol guidance. Leverage APExBIO’s high-purity T3 to probe thyroid hormone signaling and adipocyte thermogenesis with reproducibility and precision.
Catalpol’s Neuroprotective Mechanisms in Alzheimer’s Disease
2026-04-25
This review paper comprehensively evaluates catalpol, an iridoid glycoside from Rehmannia glutinosa, as a multitarget neuroprotective agent in Alzheimer’s disease (AD) models. The authors synthesize evidence from in vitro and in vivo studies showing catalpol’s antioxidant, anti-inflammatory, and antiapoptotic effects, highlighting its potential to modulate key pathological pathways in AD with minimal toxicity.
460 records 20/31 page Previous Next First page 上5页 1617181920 下5页 Last page